ABOUT US
VISION
The R&D vision of Innophore is to identify high-value industrial and therapeutic enzymes and to develop and identify enzymes for more efficient, green chemical production processes and novel biosimilars for medical treatments.
Furthermore, we strive to make important contributions to the re-purposing of drugs as well as the prediction of drug side effects with the help of our 3D point cloud technology.
TEAM
Dr. Christian Gruber
CEO
Dr. Georg Steinkellner
CTO
Prof. Karl Gruber
CSO
Christoph Blaschitz, MSc.
CFO
Dr. Mario Müller
Research Manager and coordinator
Dr. Vedat Durmaz
Senior Data Scientist
PD Dr. Andreas Krassnigg
Senior AI Strategist/Developer
Dr. Marco Cespugli
Structural Bioinformatician
PD Dr. Bettina Nestl
Senior Scientist / Key Account Management
Ursula Kahler, MSc.
Scientist
Alexander Korsunsky, MSc.
Scientific Software Developer
Michael Hetmann, MSc
Structural Bioinformatician
Amela Kurtić, BSc.
Full-Stack Developer
Daniel Nutz
Data Scientist
Klara Blaschitz
Researcher
Katharina Köchl, Bsc
Master Student
Centina König
Programmer
Mag. Sabrina Krammer, MBA
Funding
Mag. Hanna Lindermuth
Technical writing and grant coordination support
Alice Guarneri, MSc
PhD Student, ESR/PBC
Innophore GmbH is a spin-off company of acib GmbH and University of Graz and was supported as founding project by Science Park Graz GmbH in the framework of the AplusB program.
Innophore GmbH is supported by the strategic investor EOSS Industries GmbH.